Literature DB >> 17510180

Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.

Eric Hosy1, Renaud Dérand, Jean Revilloud, Michel Vivaudou.   

Abstract

ATP-sensitive K+ channels (K(ATP) channels) are metabolic sensors formed by association of a K+ channel, Kir6, and an ATP-binding cassette (ABC) protein, SUR, which allosterically regulates channel gating in response to nucleotides and pharmaceutical openers and blockers. How nucleotide binding to SUR translates into modulation of Kir6 gating remains largely unknown. To address this issue, we have used a novel conformational KATP channel inhibitor, rhodamine 123 (Rho123) which targets the Kir6 subunit in a SUR-dependent manner. Rho123 blocked SUR-less Kir6.2 channels with an affinity of approximately 1 microM, regardless of the presence of nucleotides, but it had no effect on channels formed by the association of Kir6.2 and the N-terminal transmembrane domain TMD0 of SUR. Rho123 blocked SUR + Kir6.2 channels with the same affinity as Kir6.2 but this effect was antagonized by ATP. Protection from Rho123 block by ATP was due to direct binding of ATP to SUR and did not entail hydrolysis because it was not mimicked by AMP, did not require Mg2+ and was reduced by mutations in the nucleotide-binding domains of SUR. These results suggest that Rho123 binds at the TMD0-Kir6.2 interface and that binding of ATP to SUR triggers a change in the structure of the contact zone between Kir6.2 and domain TMD0 of SUR that causes masking of the Rho123 site on Kir6.2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510180      PMCID: PMC2075286          DOI: 10.1113/jphysiol.2007.134288

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  47 in total

1.  Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1.

Authors:  Y Hou; L Cui; J R Riordan; X Chang
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

2.  A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels.

Authors:  N Zerangue; B Schwappach; Y N Jan; L Y Jan
Journal:  Neuron       Date:  1999-03       Impact factor: 17.173

3.  Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily.

Authors:  K P Hopfner; A Karcher; D S Shin; L Craig; L M Arthur; J P Carney; J A Tainer
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

4.  Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.

Authors:  N Lerner-Marmarosh; K Gimi; I L Urbatsch; P Gros; A E Senior
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.

Authors:  M Matsuo; K Tanabe; N Kioka; T Amachi; K Ueda
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

6.  Expression and characterization of the N- and C-terminal ATP-binding domains of MRP1.

Authors:  A Kern; F Felföldi; B Sarkadi; A Váradi
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

7.  Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance.

Authors:  L V Zingman; A E Alekseev; M Bienengraeber; D Hodgson; A B Karger; P P Dzeja; A Terzic
Journal:  Neuron       Date:  2001-08-02       Impact factor: 17.173

8.  Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1).

Authors:  R Daoud; C Kast; P Gros; E Georges
Journal:  Biochemistry       Date:  2000-12-19       Impact factor: 3.162

9.  The molecular basis of the specificity of action of K(ATP) channel openers.

Authors:  C Moreau; H Jacquet; A L Prost; N D'hahan; M Vivaudou
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

10.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer.

Authors:  Paul C Smith; Nathan Karpowich; Linda Millen; Jonathan E Moody; Jane Rosen; Philip J Thomas; John F Hunt
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  7 in total

1.  K(ATP) channels process nucleotide signals in muscle thermogenic response.

Authors:  Santiago Reyes; Sungjo Park; Andre Terzic; Alexey E Alekseev
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

Review 2.  Current understanding of K ATP channels in neonatal diseases: focus on insulin secretion disorders.

Authors:  Yi Quan; Andrew Barszczyk; Zhong-ping Feng; Hong-shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2011-05-23       Impact factor: 6.150

3.  Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib.

Authors:  Neeti Nadda; Shruti Setia; Vivek Vaish; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2012-09-19       Impact factor: 3.396

4.  Impact of disease-causing SUR1 mutations on the KATP channel subunit interface probed with a rhodamine protection assay.

Authors:  Eric Hosy; Julien P Dupuis; Michel Vivaudou
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

5.  β2-Adrenergic ion-channel coupled receptors as conformational motion detectors.

Authors:  Lydia N Caro; Christophe J Moreau; Jean Revilloud; Michel Vivaudou
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

6.  Role for SUR2A ED domain in allosteric coupling within the K(ATP) channel complex.

Authors:  Amy B Karger; Sungjo Park; Santiago Reyes; Martin Bienengraeber; Roy B Dyer; Andre Terzic; Alexey E Alekseev
Journal:  J Gen Physiol       Date:  2008-03       Impact factor: 4.086

7.  The unusual stoichiometry of ADP activation of the KATP channel.

Authors:  Eric Hosy; Michel Vivaudou
Journal:  Front Physiol       Date:  2014-01-28       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.